Clinical and Experimental Pediatrics

The Korean Pediatric Society (대한소아청소년과학회)
권호 표지
DOI QR코드

DOI QR Code

Recommendation for the use of newly introduced Tdap vaccine in Korea

  • Choi, Kyong-Min (The Committee on Infectious Diseases, the Korean Pediatric Society) ;
  • Kim, Kyung-Hyo (The Committee on Infectious Diseases, the Korean Pediatric Society) ;
  • Kim, Yae-Jean (The Committee on Infectious Diseases, the Korean Pediatric Society) ;
  • Kim, Jong-Hyun (The Committee on Infectious Diseases, the Korean Pediatric Society) ;
  • Park, Su-Eun (The Committee on Infectious Diseases, the Korean Pediatric Society) ;
  • Lee, Hoan-Jong (The Committee on Infectious Diseases, the Korean Pediatric Society) ;
  • Eun, Byung-Wook (The Committee on Infectious Diseases, the Korean Pediatric Society) ;
  • Jo, Dae-Sun (The Committee on Infectious Diseases, the Korean Pediatric Society) ;
  • Choi, Eun-Hwa (The Committee on Infectious Diseases, the Korean Pediatric Society) ;
  • Hong, Young-Jin (The Committee on Infectious Diseases, the Korean Pediatric Society)
  • Received : 2011.03.03
  • Accepted : 2011.04.15
  • Published : 2011.04.15
Download PDF
⟨ Previous Next ⟩

Abstract

Pertussis is an acute respiratory infection characterized by paroxysmal cough and inspiratory whoop for over 2 weeks. The incidence of pertussis has decreased markedly after the introduction of DTwP/DTaP vaccine, but the incidence of pertussis has increased steadily among young infant and among adolescents and adults in many countries. Td vaccine was used in this age group but the increase in pertussis has lead to the development of a Tdap vaccine. The Tdap vaccine is a Td vaccine with a pertussis vaccine added and is thought to decrease the incidence and transmission of pertussis in the respective age group. In Korea, two products are approved by the KOREA FOOD & DRUG ADMINISTRATION, which are ADACEL$^{TM}$ (Sanofi-Pasteur, Totonto, Ontario, Canada) and BOOSTRIX$^{(R)}$ (GlaxoSmithKline Biologicals, Rixensart, Belgium) for those aged between 11-64. This report summarizes the recommendations approved by the Committee on Infectious Diseases, the Korean Pediatric Society.

Keywords

References

  1. Crowcroft NS, Stein C, Duclos P, Birmingham M. How best to estimate the global burden of pertussis? Lancet Infect Dis 2003;3:413-8. https://doi.org/10.1016/S1473-3099(03)00669-8
  2. Pertussis--United States, 2001-2003. MMWR Morb Mortal Wkly Rep 2005;54:1283-6.
  3. Guris D, Strebel PM, Bardenheier B, Brennan M, Tachdjian R, Finch E, et al. Changing epidemiology of pertussis in the United States: increasing reported incidence among adolescents and adults, 1990-1996. Clin Infect Dis 1999;28:1230-7. https://doi.org/10.1086/514776
  4. Farizo KM, Cochi SL, Zell ER, Brink EW, Wassilak SG, Patriarca PA. Epidemiological features of pertussis in the United States, 1980-1989. Clin Infect Dis 1992;14:708-19. https://doi.org/10.1093/clinids/14.3.708
  5. Olin P, Gustafsson L, Barreto L, Hessel L, Mast TC, Rie AV, et al. Declining pertussis incidence in Sweden following the introduction of acellular pertussis vaccine. Vaccine 2003;21:2015-21. https://doi.org/10.1016/S0264-410X(02)00777-6
  6. Salmaso S, Mastrantonio P, Tozzi AE, Stefanelli P, Anemona A, Ciofi degli Atti ML, et al. Sustained efficacy during the first 6 years of life of 3-component acellular pertussis vaccines administered in infancy: the Italian experience. Pediatrics 2001;108:E81. https://doi.org/10.1542/peds.108.5.e81
  7. Jenkinson D. Duration of effectiveness of pertussis vaccine: evidence from a 10 year community study. Br Med J (Clin Res Ed) 1988;296:612-4. https://doi.org/10.1136/bmj.296.6622.612
  8. Lambert HJ. Epidemiology of a small pertussis outbreak in kent county michigan. Public Health Rep 1965;80:365-9. https://doi.org/10.2307/4592424
  9. Wendelboe AM, Van Rie A, Salmaso S, Englund JA. Duration of immunity against pertussis after natural infection or vaccination. Pediatr Infect Dis J 2005;24:S58-61. https://doi.org/10.1097/01.inf.0000160914.59160.41
  10. Mattoo S, Cherry JD. Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. Clin Microbiol Rev 2005;18:326-82. https://doi.org/10.1128/CMR.18.2.326-382.2005
  11. National, state, and urban area vaccination coverage among children aged 19-35 months--United States, 2003. MMWR Morb Mortal Wkly Rep 2004;53:658-61.
  12. Bisgard KM, Pascual FB, Ehresmann KR, Miller CA, Cianfrini C, Jennings CE, et al. Infant pertussis: who was the source? Pediatr Infect Dis J 2004;23:985-9. https://doi.org/10.1097/01.inf.0000145263.37198.2b
  13. Tanaka M, Vitek CR, Pascual FB, Bisgard KM, Tate JE, Murphy TV. Trends in pertussis among infants in the United States, 1980-1999. JAMA 2003;290:2968-75. https://doi.org/10.1001/jama.290.22.2968
  14. Park WB, Park SW, Lee KD, Lee CS, Jang HC, Kim HB, et al. Pertussis as a differential diagnosis of chronic cough in adults. Infect Chemother 2004;36:331-4.
  15. King AJ, van Gorkom T, Pennings JL, van der Heide HG, He Q, Diavatopoulos D, et al. Comparative genomic profiling of Dutch clinical Bordetella pertussis isolates using DNA microarrays: identification of genes absent from epidemic strains. BMC Genomics 2008;9:311. https://doi.org/10.1186/1471-2164-9-311
  16. Hallander HO, Advani A, Donnelly D, Gustafsson L, Carlsson RM. Shifts of Bordetella pertussis variants in Sweden from 1970 to 2003, during three periods marked by different vaccination programs. J Clin Microbiol 2005;43:2856-65. https://doi.org/10.1128/JCM.43.6.2856-2865.2005
  17. Jung SO, Moon YM, Sung HY, Kang YH, Yu JY. Serotype variations of agglutinogen and fimbriae in the Korean isolates of Bordetella pertussis . Korean J Microbiol 2008;44:221-7.
  18. Vitek CR, Pascual FB, Baughman AL, Murphy TV. Increase in deaths from pertussis among young infants in the United States in the 1990s. Pediatr Infect Dis J 2003;22:628-34.
  19. Halperin SA, Wang EE, Law B, Mills E, Morris R, Dery P, et al. Epidemiological features of pertussis in hospitalized patients in Canada, 1991-1997: report of the Immunization Monitoring Program--Active (IMPACT). Clin Infect Dis 1999;28:1238-43. https://doi.org/10.1086/514792
  20. Lee GM, Lett S, Schauer S, LeBaron C, Murphy TV, Rusinak D, et al. Societal costs and morbidity of pertussis in adolescents and adults. Clin Infect Dis 2004;39:1572-80. https://doi.org/10.1086/425006
  21. De Serres G, Shadmani R, Duval B, Boulianne N, Dery P, Douville Fradet M, et al. Morbidity of pertussis in adolescents and adults. J Infect Dis 2000;182:174-9. https://doi.org/10.1086/315648
  22. Senzilet LD, Halperin SA, Spika JS, Alagaratnam M, Morris A, Smith B. Pertussis is a frequent cause of prolonged cough illness in adults and adolescents. Clin Infect Dis 2001;32:1691-7. https://doi.org/10.1086/320754
  23. Lievano FA, Reynolds MA, Waring AL, Ackelsberg J, Bisgard KM, Sanden GN, et al. Issues associated with and recommendations for using PCR to detect outbreaks of pertussis. J Clin Microbiol 2002;40:2801-5. https://doi.org/10.1128/JCM.40.8.2801-2805.2002
  24. Lind-Brandberg L, Welinder-Olsson C, Lagergard T, Taranger J, Trollfors B, Zackrisson G. Evaluation of PCR for diagnosis of Bordetella pertussis and Bordetella parapertussis infections. J Clin Microbiol 1998;36:679-83.
  25. He Q, Viljanen MK, Arvilommi H, Aittanen B, Mertsola J. Whooping cough caused by Bordetella pertussis and Bordetella parapertussis in an immunized population. JAMA 1998;280:635-7. https://doi.org/10.1001/jama.280.7.635

Cited by

  1. Pertussis Seroprevalence in Korean Adolescents and Adults Using Anti-Pertussis Toxin Immunoglobulin G vol.29, pp.5, 2011, https://doi.org/10.3346/jkms.2014.29.5.652
  2. Pertussis Prevalence in Korean Adolescents and Adults with Persistent Cough vol.30, pp.7, 2011, https://doi.org/10.3346/jkms.2015.30.7.988
  3. Knowledge and Acceptability about Adult Pertussis Immunization in Korean Women of Childbearing Age vol.56, pp.4, 2011, https://doi.org/10.3349/ymj.2015.56.4.1071
  4. Assessment of safety and efficacy against Bordetella pertussis of a new tetanus-reduced dose diphtheria-acellular pertussis vaccine in a murine model vol.17, pp.None, 2011, https://doi.org/10.1186/s12879-017-2369-x
  5. A 6-year Prospective, Observational, Multi-Center Post-Marketing Surveillance of the Safety of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis (Tdap) Vaccine in Korea vol.34, pp.12, 2019, https://doi.org/10.3346/jkms.2019.34.e105
  6. A systematic review of the burden of pertussis in South Korea vol.17, pp.6, 2021, https://doi.org/10.1080/21645515.2020.1844505